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BACKGROUND: Transparency when documenting and assessing weight of evidence (WOE) has been an area of increasing focus for national and inter-
national health agencies.
OBJECTIVE: The objective of this work was to conduct a critical review of WOE analysis methods as a basis for developing a practical framework for
considering and assessing WOE in hazard identiﬁcation in areas of application at the French Agency for Food, Environmental and Occupational
Health and Safety (ANSES).
METHODS: Based on a review of the literature and directed requests to 63 international and national agencies, 116 relevant articles and guidance docu-
ments were selected. The WOE approaches were assessed based on three aspects: the extent of their prescriptive nature, their purpose-speciﬁc rele-
vance, and their ease of implementation.
RESULTS: Twenty-four approaches meeting the speciﬁed criteria were identiﬁed from selected reviewed documents. Most approaches satisﬁed one or
two of the assessed considerations, but not all three. The approaches were grouped within a practical framework comprising the following four stages:
(1) planning the assessment, including scoping, formulating the question, and developing the assessment method; (2) establishing lines of evidence
(LOEs), including identifying and selecting studies, assessing their quality, and integrating with studies of similar type; (3) integrating the LOEs to
evaluate WOE; and (4) presenting conclusions.
DISCUSSION: Based on the review, considerations for selecting methods for a wide range of applications are proposed. Priority areas for further devel-
opment are identiﬁed. https://doi.org/10.1289/EHP3067
Introduction
Risk assessment is usually characterized by four components:
hazard identiﬁcation, hazard characterization (including dose–
response analysis), exposure assessment, and risk characteriza-
tion. Identifying relevant hazards for subsequent consideration
in dose–response analysis and risk characterization requires the
assimilation and assessment of a wide range of diﬀerent types
of data (NRC 2014; OECD 2014; U.S. EPA 2014). Variations
in conclusions drawn by diﬀerent organizations on the potential
of speciﬁc substances to cause hazards in such assessments
have highlighted the need for greater consistency in the analysis
of such data. Examples include variations among the conclu-
sions of the European Food Safety Agency (EFSA), the U.S.
Environmental Protection Agency (U.S. EPA 2017), and the
International Agency for Research on Cancer (IARC) regarding
the carcinogenicity of glyphosate (EFSA 2017) and among those
of the EFSA, the ANSES, and the U.S. National Toxicology
Program on the reproductive/developmental hazards of bisphenol
A (ANSES 2015; U.S. NTP 2008). These variations have led to
an increasing focus of national and international agencies on the
robustness and transparency of expert-informed assessments
(Hardy et al. 2015; OHAT 2015) as a basis for increasing the
understanding and conﬁdence of the relevant scientiﬁc commu-
nity, stakeholders, and the public. Although the term “weight of
evidence” (WOE) appears frequently in the scientiﬁc literature, it
is often poorly and inconsistently deﬁned, with limited documen-
tation of the supporting expert-informed process and methodol-
ogy (NRC 2014; Weed 2005).
For example, WOE has long been referenced in a range of
disciplines, including the medical sector, where it was introduced
principally as a clinical decision-support tool for prioritizing
knowledge of medical research, focusing on a critical review
of the literature (Sackett et al. 1996). WOE assessment has also-
been widely referenced and applied in environmental health
(Mandrioli and Silbergeld 2016; Krimsky 2005). In various disci-
plines, approaches to the assessment of WOE have evolved
beyond a review of the literature to include expert-informed
reviews and the integration of diﬀerent types of information in a
transparent and systematic manner (e.g., meta-analysis). The
reviews of Linkov et al. (2009) and Rhomberg et al. (2013)
described a wide range of approaches, ranging from those that
are largely qualitative in nature (e.g., Guyatt et al. 2011a) to
fully quantitative techniques (e.g., Gosling et al. 2013). The
inclusiveness and organization of diﬀerent approaches vary,
with some including references to establishing lines of evidence
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(i.e., groupings of evidence of similar types to assess a hypothe-
sis) and integrating evidence of diﬀerent types (e.g., toxicologi-
cal, epidemiological, and mechanistic data). Others address only
integrating diﬀerent types of evidence without reference to the
prerequisite stages, such as identifying and selecting relevant
evidence and establishing “lines of evidence” (LOEs). A frame-
work has been proposed here, then, to support the selection of
WOE methodologies, depending on the objectives and focus of
assessments.
The speciﬁc objective of this work was to propose harmon-
ized approaches to assessing and communicating WOE in envi-
ronmental, occupational, and food safety, as well as plant and
animal health, for the French Agency for Food, Environmental
and Occupational Health and Safety (ANSES). The review was
limited to considering documented approaches to WOE assess-
ment (interpreted here as the structured synthesis of evidence)
and did not address issues related to the selection of experts and
conﬂicts of interest.
The scope and basis of the current review are broader than
those of earlier reviews by, for example, Rhomberg et al. (2013),
which was conﬁned to chemical hazards to human health. The
review addresses approaches relevant to a wide range of applica-
tions within the purview of ANSES, including, for example,
microbiological quality. It includes not only an extensive review
of the literature through PubMed and Scopus but also a focused
consultation of 63 public health and environmental agencies
worldwide and characterizes identiﬁed approaches in component
stages of the proposed practical framework for WOE analysis,
relevant to this broader range of assessments. Each approach is
also rated according to three criteria assessing their prescriptive
nature, relevance, and feasibility for screening of their potential
for application within ANSES and possibly within other food and
environmental safety agencies.
Methods
Both peer-reviewed journal articles and guidance developed by
health and environmental agencies were considered in the review.
To limit the search to WOE assessment in risk analysis, the query
of the review was composed of the combination of two sets of
terms using the AND operator, with the ﬁrst one related to WOE
and the second one related to risk analysis (Figure 1). Two data-
bases were queried on 16 March 2015 (i.e., Scopus and PubMed),
and the title, summary, and keyword sections were searched.
Papers were excluded if they were published before 2010 and after
March 2015 and in languages other than English or French, as
were case studies, editorials, or papers without identiﬁable content
related to WOE approaches.
Sixty-three national and international agencies or organiza-
tions performing risk assessment were also consulted to identify
relevant guidance (Table S1). Additional documents identiﬁed
from the lists of references in the selected articles and relevant
reports were also reviewed. Titles and abstracts were screened by
at least two people. Descriptions of the approaches based on
extraction and assessment of relevant information were com-
pleted for each selected article by individual authors within their
area of expertise and were reviewed collectively by all the
authors of this manuscript. Critical aspects included the domain
and scope of the study, the deﬁnition of terms (e.g., WOE)
and the approach and methodology for WOE assessment, includ-
ing the nature and number of considerations taken into account
for the stage or stages of assessment addressed by the approach
(Figure S1).
For application in assessment planning at ANSES, these
descriptions were also considered collectively by the authors to
characterize and relatively rank the following aspects (Table 1):
• The “extent of their prescriptive nature” which contributes to
transparency and reproducibility. This consideration addressed
the degree of prescription of the factors assessed in consider-
ing the quality and subsequent weighting of studies and bodies
of evidence and often derives from the extent of expert-
informed experience in developing and applying the approach
(i.e., approaches based on extensive application experience are
often more prescriptive). Relative ranking was based on the
extent to which considerations for implementation were pre-
cisely delineated and deﬁned in the various approaches and
ranged from “no explicit rules provided” (rank= 1) to “imple-
mentation rules deﬁned in signiﬁcant detail, facilitating use by
non-experts” (rank= 4).
• “Relevance” was related to the extent to which the approaches
could be broadly applied within the types of assessments con-
ducted within ANSES. For example, were they speciﬁc to
specialized components or aspects of WOE consideration
(e.g., mechanistic data), or were they more broadly applicable
to all aspects of assessments of hazard commonly conducted
within ANSES? Rankings ranged from “the speciﬁcity of the
methodology restricts its use to a relatively narrow applica-
tion for which it was developed” (rank= 1) to “the methodol-
ogy is suﬃciently generic to be broadly applicable to most
aspects of a broad range of assessments of hazard within
ANSES” (rank= 4).
Figure 1. Keywords combined to produce the Scopus and PubMed search query.
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• “Ease of implementation” (feasibility) in terms of time and
material/human resources, including the requirement for
speciﬁc and often advanced methodological skills (model-
ing, statistics, etc.). Relative ranking of the ease of imple-
mentation was based on the extent of complexity of the
approach and the associated nature and extent of required
experience, skills, time, and material resources for applica-
tion. Scores ranged from “resource intensive, requiring
considerable resources and expertise” (rank= 1) to “limited
requirement for specialized expertise, material resources
and/or time” (rank= 4).
Results
The study selection process is described in Figure 2. The study
selection process is described in Figure 2, using PRISMA
(Moher et al. 2009). In all, 643 articles identiﬁed in the Scopus
and PubMed searches, 25 relevant reports from agencies, and
67 documents from the screening of the associated lists of
references were retrieved. This corresponded to 663 documents
after the removal of duplicates. We reviewed the titles and
abstracts of the 663 documents and excluded 538 due to the
lack of reference to WOE in the title or abstract or the lack of a
description of a WOE approach. We reviewed the remaining
125 full-text articles for eligibility and excluded 9 because the
reported data were not relevant to the objective of the paper.
The remaining 116 documents formed the principal basis for
the current review/analysis. Twenty-four relevant approaches
were identiﬁed in the 116 selected documents (Table 2). A pre-
vious review of WOE frameworks was also identiﬁed in the
selected documents, i.e., Rhomberg et al. (2013).
Each of the methods/frameworks cited in Table 2 has been
applied in one or more ﬁelds (Table 3). A wide range of
approaches has been adopted in environmental health, food
safety and nutrition, and medical applications. The most com-
monly adopted approaches based on the numbers of examples
of applications in diﬀerent domains are IARC classiﬁcations,
followed by Bradford Hill considerations in the assessment of
Table 1. Ranking considerations for the prescriptive nature, relevance, and feasibility of WOE approaches for ANSES evaluations.
Consideration Rank Ranking
Prescriptive nature 1 No explicit rules
2 Some methodological elements for assessment and weighting defined but insufficiently detailed for non-expert users
3 Implementation rules are well defined for most aspects of the WOE assessment
4 Implementation rules are defined in sufficient detail to permit application by non-expert users
Relevance 1 The specificity of the methodology restricts its use to specialized aspects or applications of WOE assessment for which it
was developed
2 The methodology can be applied for a limited range of aspects or applications in hazard assessment within ANSES
3 The methodology is applicable to most aspects or applications of a broader range of assessments of hazard within ANSES
4 The methodology is sufficiently generic to be applicable to most aspects of a broad range of assessments of hazard within
ANSES
Feasibility 1 Implementation of the method is resource intensive (complexity high) and requires considerable specialized expertise and/
or material resources
2 Implementation of the method impacts moderately on resources (moderate complexity), requiring some specific training
3 Implementation of the method impacts minimally on resources and does not require specialized training, expertise and/or
material resources
4 Implementation of the method not anticipated to impact significantly on timeframe and resources for assessment
Figure 2. Flow diagram of the study selection process using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA, Moher et al. 2009).
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Table 2.WOE Approaches identified in the literature.
Name Description Category
SR
included
Form of
evaluationa
PF stages
(step of stage) Reference
AMSTAR Assessment of syntheses of observational and
clinical studies through the scoring
(1–4) of 11 aspects
Method Yes Scoring 2 (2) Kung et al. (2010); Pieper et al. (2015);
Shea et al. (2007a, 2007b, 2009)
Bayesian
inference
Statistical analysis combining expert knowledge
(described by a prior probability distribution)
with data to estimate a quantity of interest and
analyze uncertainty
Method No Quantitative 3;
4
BioBayes Group (2015); Gosling et al.
(2013); Guha et al. (2013); Schleier
et al. (2015); Spiegelhalter et al.
(2004); Williams et al. (2011)
Bradford Hill Qualitative consideration of causality
(9 aspects) in epidemiological studies
Method No Qualitative 2 (3);
3
ANSES (2012) Bergman et al. (2015);
Guzelian et al. (2005); Hill (1965);
Rothman and Greenland (2005);
Vinken (2013)
Decision tree Tool based on a tree-like graph describing
options for various decision points
Method No Qualitative or
quantitative
3 ANSES (2013a, 2013b); FAO/WHO
(2001); Khosrovyan et al. (2015);
Metcalfe (2005)
Epid-Tox Grid based on a five-step process to evaluate the
quality of epidemiological and toxicological
studies, and their intersection, to establish
causal inference
Method No Qualitative 2 (2);
2 (3);
3;
4
Adami et al. (2011); ECETOC (2009)
FDA Qualitative evaluation of individual studies in
humans and of the total scientific evidence
based on study type, quantity of evidence, rele-
vance to the target population, replication of
study results and overall consistency
Method No Qualitative 2 (1);
2 (2);
2 (3)
FDA (2009)
GRADE Assessment of methodological flaws within the
component studies, the consistency of results
across different studies, the generalizability of
research results to the wider patient base, and
the effectiveness of treatments
Method Yes Scoring 1;
2 (2);
2 (3);
4
Akl et al. (2007); Andrews et al.
(2013a, 2013b); Balshem et al.
(2011); Berkman et al. (2012); Guyatt
et al. (2011a, 2011b, 2011c, 2011d,
2011e, 2011f, 2011g, 2011h, 2011i);
HAS (2013); Kho and Brouwers
(2012); WHO (2012)
Hope and
Clarkson
Weighting and integration of information relat-
ing cause and effect to estimate the probability
of an adverse outcome for an ecological
assessment endpoint
Framework No Scoring 1;
2 (2);
2 (3);
3;
4
Hope and Clarkson (2014)
Hypothesis-
based
Fully expert-dependent assessment for various
hypotheses for hazard identification of chemi-
cal substances
Method No Qualitative 3;
4
Bailey et al. (2016); Rhomberg (2015)
IARC Assessment of the quality of individual studies
based on “principles of good practice” without
reporting templates. Four categories for classi-
fication of combined evidence on toxicology
and epidemiology and three for mode of
action. Expert dependent
Method No Qualitative 2 (2);
2 (3);
3;
4
IARC (2006)
ILSI Set of qualitative criteria to assess evidence on
allergens proposed by the International Life
Sciences Institute (ILSI) Europe Food Allergy
Task Force
Method No Rank
ordering
2 (2);
2 (3)
Van Bilsen et al. (2011)
INCa Criteria to assess evidence on nutritional factors
and their associated cancer risk
Method No Qualitative 2 (3);
3;
4
INCa (2015)
Klimisch Scoring of the quality of individual toxicologi-
cal studies based on limited indicators for reli-
ability, relevance, and adequacy of data
Method No Scoring 2 (2) ECHA (2011); Klimisch et al. (1997);
Money et al. (2013); Schneider et al.
(2009)
Meta-analysis Statistical analysis of data collected in separate
but similar studies, leading to the estimation of
the magnitude of an effect and associated con-
fidence interval
Method Yes Quantitative 2 (3) Chalmers et al. (2002); EFSA (2014);
Goodman et al. (2010); Marvier et al.
(2007, 2011); Moher et al. (2015);
Murad et al. 2014
Modified
Bradford Hill
Comparative analysis for alternative mode of
action hypotheses based on rank ordering of a
subset of Bradford Hill considerations, taking
into account epidemiological, toxicological
and mechanistic data
Method No Rank
ordering
3;
4
Boobis et al. (2006, 2008); Meek 2008;
Meek et al. (2003, 2014a, 2014b);
OCDE (2014)
Note: AMSTAR, Assessing the Methodological Quality of Systematic Reviews; EFSA, European Food Safety Authority; FDA, U.S. Food and Drug Administration; GRADE,
Grading of Recommendations Assessment, Development and Evaluation; IARC, International Agency for Research on Cancer; ILSI, International Life Sciences Institute; INCa,
Institut National du Cancer/French National Cancer Institute; NRC, U.S. National Research Council; OHAT, Office of Health Assessment and Translation; PF, Practical Framework;
SCENIHR, Scientific Committee on Emerging and Newly Identified Health Risks; SR, Systematic Review; WCRF/AICR, World Cancer Research Fund and American Institute for
Cancer Research; WHO, World Health Organization.
aSemiquantitative refers to approaches that include scoring and rank ordering of various components, without quantitation.
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causality in epidemiological studies, modiﬁed Bradford Hill
considerations in mode of action analyses, expert rule-based deci-
sion trees and systematic reviews proposed by EFSA (SR-EFSA).
As expected, the methodologies proposed by the Cochrane
Collaboration (SR-Cochrane) have only been adopted within the
medical community, whereas Grading of Recommendations,
Assessment, Development, and Evaluations (GRADE) guidelines
have also been applied in the nutrition and environmental health
ﬁelds.
Frameworks for Assessing the Body of Evidence
Of the 24 WOE approaches identiﬁed in Table 2, Hope and
Clarkson (2014), U.S. National Research Council (NRC 2014),
Oﬃce of Health Assessment and Translation (OHAT 2015),
Scientiﬁc Committee on Emerging and Newly Identiﬁed Health
Risks (SCENIHR 2012), and Rhomberg et al. (2013) addressed
more than one stage of systematic data compilation, assessment
and integration. These ﬁve approaches are subsequently referred
to here as frameworks, and the other 19 are described as methods.
Based on the deﬁnitions identiﬁed in the literature review
(Table S2), LOE and WOE are deﬁned in the practical framework
proposed here as follows:
• An LOE is a set of relevant items of information of similar
type grouped to assess a hypothesis; and
• WOE is the structured synthesis of lines of evidence, possi-
bly of varying quality, to determine the degree of support for
hypotheses.
The term “strength of evidence,” although appearing in some
of the selected documents, was deﬁned diﬀerently in varying con-
texts related to WOE by diﬀerent authors, e.g., as a constitutive
element of WOE (Suter and Cormier 2011; Linkov et al. 2009) or
as a distinct entity (EFSA 2010). Subsequently, no deﬁnition is
elaborated here.
The ﬁve identiﬁed frameworks diﬀer in terms of the number
of stages and level of detail (Figure 3). Three frameworks –
namely, those of the NRC, Hope and Clarkson, and OHAT –
address planning, scoping, problem formulation, and protocol de-
velopment. Rhomberg et al. (2013) deﬁne causal questions and
identify criteria for study selection. All ﬁve of the frameworks
distinguish additional steps in establishing LOEs, namely, identi-
ﬁcation and selection of studies and an evaluation of their quality
(based on speciﬁc criteria), and an assessment of LOEs. For all
ﬁve frameworks, weighting and/or integrating one or more LOEs
to assess WOE is addressed, and, lastly, conclusions are
drawn. To support conclusions, SCENIHR adds an expression of
Table 2. (Continued.)
Name Description Category
SR
included
Form of
evaluationa
PF stages
(step of stage) Reference
Multi-criteria
analysis
Expert-based quantitative judgment of quality
of studies and their integration, including sen-
sitivity and uncertainty analysis
Method No Quantitative
or scoring
2 (2);
2 (3);
3;
4
Hristozov et al. (2014a, 2014b);
Linkov et al. (2009), 2011; U.S. EPA
(1997, 2003)
Navigation
Guide
Synthesis of results for the reproductive and de-
velopmental hazards of chemical agents in the
research context through 4 steps focused prin-
cipally on systematic review
Method Yes Scoring 2 (1);
2 (3);
3
Viswanathan et al. (2012); Woodruff
and Sutton (2011, 2014)
NRC Principal focus on systematic review Framework Yes Scoring 1; 2 (1);
2 (2);
3; 4
NRC 2014
OHAT Detailed documentation of components for all
stages
Framework Yes Scoring 1; 2 (1); 2 (2);
2 (3);
3; 4
Howard et al. (2014); OHAT (2015);
Rooney et al. (2014); U.S. NTP
(2015)
SCENIHR Considerations to address individual studies in 3
categories for quality and relevance and 3 cate-
gories for coherence between studies of similar
type with weighting of lines of evidence by
utility/coherence
Framework No Scoring 2 (1); 2 (2);
2 (3);
3; 4
SCENIHR (2012)
SR-Cochrane Handbook for Systematic Reviews of
Interventions. Planning: PICO for question for-
mulation, detailed specification of search strat-
egy, documentation of bias in study selection
and presentation of results, their applicability,
quality (in 4 categories) and outcome
(EPICOT)
Method Yes Qualitative 1;
2 (1); 2 (2);
4
Bilotta et al. (2014); Higgins and
Green (2011); Mandrioli and
Silbergeld (2016); O'Connor et al.
(2011); Schünemann et al. (2011)
SR-EFSA Detailed planning, process and documentation
of systematic review, including PICO, PECO,
PIT and PO and selection of studies (modifica-
tion of SR-Cochrane)
Method Yes Qualitative 1;
2 (1);
4
EFSA (2010)
WCRF/AICR Classification regarding nutrition and cancer
risk relationships. Evaluation of individual
studies (epidemiological and mechanistic)
based on good practice, meta-analysis of epi-
demiological studies identified through sys-
tematic review, and consideration of
mechanistic data in relation to the biological
plausibility of human data. Classification of
WOE for each nutritional factor in 5 classes
Method Yes Qualitative 2 (2); 2 (3);
3;
4
WCRF/AICR (2014)
Weighted
Bradford Hill
Estimation of the probability of causality in epi-
demiological studies through expert assess-
ment of the extent of supporting data for each
of 9 weighted Bradford Hill considerations
Method No Quantitative 2 (3);
3
Swaen and van Amelsvoort (2009)
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uncertainty, and Hope and Clarkson estimate ecological risk
based on WOE.
Based on this analysis, and in view of the broad scope of
ANSES expert-informed evaluations, a practical framework includ-
ing four main stages is proposed here (Figure 4). The four stages
are as follows: planning the assessment, establishing LOEs, integrat-
ing LOEs, and expressing WOE conclusions. For each stage of this
framework, the identiﬁed methods were considered according to the
three aspects introduced above, namely, the extent of their prescrip-
tive nature, relevance, and feasibility.
The aim of formally documenting assessment planning (stage 1)
is to increase transparency in the focus and methodology selected
for the assessment. This ﬁrst stage has three operational steps:
• Scoping (i.e., determining the appropriate focus, based on
the objectives and preliminary consideration of available
data),
• Formulating the question(s) to be assessed, and
• Developing the protocol for WOE assessment
Establishing LOEs (stage 2) also has three operational steps:
• Identifying and selecting studies
• Assessing the quality of the studies; and
• Analyzing a set of studies of similar type (epidemiological,
toxicological, etc.) to establish LOEs.
Stage 3 addresses the integration of data from available LOEs
to establish WOE in order to determine the degree of support for
hypotheses or to estimate quantities of interest.
The objective of Stage 4 (i.e., the formal expression of con-
clusions) is an explicit presentation of WOE in a form that maxi-
mally supports decision-making.
Stages of WOE Addressed in the Identified Methods
Each method/framework identiﬁed in the literature addresses one
or more key stages and steps of the WOE practical framework
presented in Figure 4. Most address steps 2 (assessing the quality
of the studies) and 3 (analyzing studies of similar type to estab-
lish LOEs) of stage 2, stage 3 (integration to establish WOE), and
stage 4 (formal expression of conclusions). Few of them consider
stage 1 (assessment planning) and step 1 of stage 2 (systematic
identiﬁcation and selection of studies) (see column on stages/
steps addressed in Table 2).
Stage 1. Assessment planning. Stage 1 is addressed in six
approaches: Hope and Clarkson (2014), NRC (2014), OHAT
(2015), GRADE (Guyatt et al. 2011a), SR-Cochrane (Higgins
and Green 2011), and SR-EFSA (EFSA 2010). Hope and
Clarkson, NRC, and OHAT diﬀerentiate between the three opera-
tional steps as shown in Figure 4.
Step 1. Scoping. Hope and Clarkson describe the objective
of scoping as deﬁning environmental management objectives
with stakeholders in neutral, precise, and measurable terms.
NRC outlines these objectives as understanding the needs of cli-
ents in evaluating chemical products or processes. For OHAT,
the aims are presented as identifying participants, evaluating
the impact of conducting an evaluation and identifying the on-
going and related components of the assessment to be devel-
oped. For GRADE, scoping is not considered, as this method is
devoted to the examination of alternative clinical management
strategies or interventions.
For problem formulation in the consideration of environmen-
tal risk (including exposure and hazard), Hope and Clarkson sug-
gest developing a conceptual model for each question and sub-
question. These authors describe a conceptual model as a diagram
that illustrates the succession of risk hypotheses based on pre-
dicted relationships among sources, stressors, exposures and
assessment endpoint responses.
Step 2. Formulating the question(s). NRC formulates the
problem based on a matrix outlining the testing strategy (i.e., the
nature of the eﬀects to be investigated in speciﬁed testing
Table 3. Areas of application for the 24 WOE approaches screened by the literature review.
Approachesa
Safety at
work
Food
microbiology
Food
chemistry Nutrition
Animal feed
and health
Environmental
health
Crop protection products,
biocides and fertilizers Medical
Ecology-
environment
AMSTAR X
Bayesian inference X X
Bradford Hill X X X X
Decision tree X X X X
Epid-Tox X X X
FDA X X
GRADE X X X
Hope and Clarkson X
Hypothesis based X
IARC X X X X X X
ILSI X
INCa X X
Klimisch X X X
Meta-analysis X X X
Modified Bradford Hill X X X X
Multi-criteria analysis X X X
Navigation Guide X
NRC X X
OHAT X
SCENIHR X
SR-Cochrane X
SR-EFSA X X X X
WCRF/AICR X X
Weighted Bradford Hill X
Note: AMSTAR, Assessing the Methodological Quality of Systematic Reviews; EFSA, European Food Safety Authority; FDA, U.S. Food and Drug Administration; GRADE,
Grading of Recommendations Assessment, Development and Evaluation; IARC, International Agency for Research on Cancer; ILSI, International Life Sciences Institute; INCa,
Institut National du Cancer/French National Cancer Institute; NRC, U.S. National Research Council; OHAT, Office of Health Assessment and Translation; PF, Practical Framework;
SCENIHR, Scientific Committee on Emerging and Newly Identified Health Risks; SR, Systematic Review; WCRF/AICR, World Cancer Research Fund and American Institute for
Cancer Research.
aDescriptions of approaches and associated references are included in Table 2.
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protocols (in vivo, in vitro, etc.). OHAT and GRADE adopt the
PECO reporting template (population, exposure, comparator, and
outcome). The latter is derived from PICO elements (patient/prob-
lem/population, intervention, comparator, and outcome) promoting
well-developed clinical questions in evidence-based medicine. In
addition, NRC and OHAT propose working with a systematic
review (SR) specialist but do not speciﬁcally outline the require-
ments for systematic review. The SR-Cochranemethod has adapted
the PICO reporting templates, whereas OHAT has developed
PECOTS by adding the elements of time (T) and information on the
setting of interest (S). SR-EFSA recommends additional tem-
plates for assessing the accuracy of a test result and quantifying a
scenario of interest (prevalence, for instance) and has developed
a method for completing the templates based on the literature.
Step 3. Developing the assessment protocol. For protocol
development in assessment planning, Hope and Clarkson and
NRC list assessment methods to establish LOEs and key ele-
ments of a systematic review, respectively. OHAT has developed
a reporting template for a detailed analysis that includes scoping
elements, the PECO template, and a description of all methods of
analysis, from evidence identiﬁcation to the development and
presentation of conclusions. OHAT also recommends the use of
text-mining, e.g., SWIFT (Howard et al. 2014), to characterize
the extent and nature of available data. SR-EFSA recommends
that the criteria for study inclusion or exclusion, the methodology
adopted for each step of stage 2, and the process for the conduct-
ing the review (i.e., the composition of the multidisciplinary
team, the timetable, and allocated resources) be speciﬁed to
reduce the risk of bias— thus limiting their later criticism— and
to increase the level of repeatability. GRADE consists of distin-
guishing the importance of outcomes in three steps, i.e., specify-
ing all potential patient-important outcomes in their endeavor,
Figure 3. Stages addressed in the ﬁve WOE frameworks identiﬁed in the literature.
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distinguishing between critical and important-but-not-critical out-
comes and making judgments about the balance between the de-
sirable and undesirable eﬀects of an intervention.
The approaches proposing a reporting template for one or
more of the substeps (i.e., SR-EFSA and OHAT) are considered
to be the most prescriptive and, as such, they promote transpar-
ency in assessment planning (Table 4). Generally, then, for
assessment planning, GRADE, NRC, OHAT, SR-Cochrane, and
SR-EFSA are equally prescriptive, but are more prescriptive than
Hope and Clarkson (Table 4) because the latter authors do not pro-
pose a reporting template. NRC, OHAT, GRADE, SR-Cochrane,
and SR-EFSA are considered broadly applicable or relevant,
whereas the application of Hope and Clarkson is limited to the
estimation of ecological risk.
Stage 2. Establishing LOEs. Nineteen methods address the
collection and consideration of data to establish LOEs.
Step 1. Identification and selection of studies. Five methods/
frameworks consider Step 1: the Navigation Guide (Woodruﬀ
and Sutton 2014), OHAT (2015), SR-Cochrane (Higgins and
Green 2011), SR-EFSA (EFSA 2010), and Institut National du
Cancer/French National Cancer Institute (INCa 2015), primarily
through systematic literature review, the objective of which is to
limit bias in the assembly, critical appraisal, and synthesis of all
relevant studies. The principles adopted by SR-Cochrane, SR-
EFSA, IARC, and OHAT are the use of at least two databases,
the selection of studies by two independent reviewers, and the
identiﬁcation of the study selection criteria and data extraction
format prior to the review. These approaches are considered pre-
scriptive and relevant, but the requirement for considerable
human resources makes them less feasible (Table 5). INCa is
considered prescriptive and feasible. However, its relevance is
limited to consideration of meta-analysis only in the establish-
ment of LOEs.
Step 2. Assessing the quality of the studies. The quality of
relevant studies considered in the establishment of LOEs is usu-
ally assessed according to the degree of transparency in the docu-
mentation of the methodology, analysis and results, and the
degree to which potential methodological bias, such as informa-
tion and selection bias, is considered. Alternatively, or in addi-
tion, quality is assessed by the extent and nature of the scientiﬁc
data (e.g., whether supporting data are direct or indirect). Two
types of assessment methods are presented in the literature, i.e.,
those with or without quantitative scoring.
IARC (2006), WCRF/AICR (2014), SR-Cochrane (Higgins
and Green 2011), and FDA (2009) are based on a qualitative
evaluation of studies, i.e., without scoring. The evaluation criteria
relate to good research practices for each area (epidemiology,
toxicology, etc.). Epid-Tox (Adami et al. 2011) adopts criteria
proposed by the U.S. EPA (2001) for evaluating toxicological
studies and those from the European Centre for Ecotoxicology
and Toxicology of Chemicals (ECETOC 2009) for assessing
epidemiological studies in three categories: “reliable without
restriction” (minimum limitations), “reliable with restrictions”
(moderate limitations), and “not reliable” (limitations suﬃcient
to be excluded from WOE assessment). The extent of prescrip-
tion of the qualitative methods is generally low, a function of
their being expert-dependent with a varying degree of transpar-
ency in the considerations of the resulting judgments. Their sim-
plicity makes them feasible, and they are broadly applicable or
relevant (Table 5).
In multicriteria decision analysis (Linkov et al. 2011),
Hope and Clarkson, GRADE, OHAT, International Life Sciences
Institute (ILSI) (Van Bilsen et al. 2011), and Klimisch (Klimisch
Figure 4. Practical framework for weight of evidence assessment.
Table 4. Ranking of the methods for planning the assessment.
Approach Prescriptive naturea Relevancea Feasibilitya
GRADE 4 3 3
Hope and Clarkson 2 2 3
NRC 4 3 3
OHAT 4 3 3
SR-Cochrane 4 3 3
SR-EFSA 4 3 3
Note: GRADE, Grading of Recommendations Assessment, Development and Evaluation;
EFSA, European Food Safety Authority; NRC, U.S. National Research Council; OHAT,
Office of Health Assessment and Translation; SR, Systematic Review.
aThe rankings were assigned to the methods by the authors collectively and reflect rela-
tive consideration of each of the three aspects defined and outlined in the Methods and
Table 1: the extent of prescriptive nature contributing to transparency and reproducibil-
ity, relevance to be broadly applied within ANSES, and ease of implementation in terms
of time and material/human resources (feasibility). Each aspect is ranked from 1 (i.e.,
the least) to 4 (i.e., the most).
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et al. 1997) attribute scores to individual studies, taking into
account their quality. The tools proposed by GRADE and OHAT
enable the classiﬁcation of study quality on a qualitative scale
based on a set of questions. For instance, the OHAT Bias Risk
Tool is composed of eleven questions related to good research
practices for various types of studies. A response to a question is
expressed in terms of risk of bias (low, probably low, probably
high, and high). Multicriteria decision analysis and Hope and
Clarkson score individual studies based on a quantitative scale
according to speciﬁc criteria. For example, Hope and Clarkson
address ﬁve criteria, i.e., study quality, use of standard methods to
design the study, site speciﬁcity, spatial representativeness, and
temporal representativeness. Each of these criteria is scored in bi-
nary fashion for each study, with the value of 1 corresponding to
criteria eﬀectiveness for each of the ﬁve LOEs, each one address-
ing a speciﬁc aspect, i.e., endpoint/attribute association, exposure/
response function, sensitivity to stressor, speciﬁcity to stressor,
and quantiﬁcation of response. The weighting for each LOE is
then calculated by combining the criteria scores.
None of these methods prescribes a quantitative threshold
value for exclusion. Criteria speciﬁed by the Klimisch, Hope and
Clarkson, and multicriteria decision analysis methods are less
speciﬁc (i.e., less prescriptive) than those of GRADE and OHAT.
Each of the methods considered in this section, i.e., multicriteria
decision analysis, Hope and Clarkson, GRADE, OHAT, ILSI,
and Klimisch, is considered relevant and feasible (Table 5).
Assessing the Methodological Quality of Systematic Reviews
(AMSTAR) and its revised version R-AMSTAR are the only
methods considered here that address the quality of a synthesis
of studies. The methodology is relatively prescriptive, delineat-
ing a questionnaire with eleven items to score, contributing to
transparency and reproducibility of reviews. Although relevant
for the assessment of syntheses of both clinical trials and obser-
vational studies, the method addresses only one component of
one stage of the developed practical framework. The method is
also considered feasible, requiring limited time to develop the
score.
Step 3. Analyzing a set of studies of similar type. Fourteen
methods/frameworks include considerations for establishing
LOEs of similar type. Meta-analysis and all methods based on
meta-analyses of epidemiological studies are considered prescrip-
tive, as speciﬁed elements of the considered studies must be suﬃ-
ciently similar to enable their statistical analysis (Chalmers et al.
2002). These include WCRF/AICR, which systematically per-
forms meta-analyses in all its nutrition–cancer evaluations; IARC,
which commissions speciﬁc meta-analyses for selected topics,
such as asbestos and ovarian cancer; or INCa, which performs sys-
tematic reviews of published meta-analyses on nutrition and can-
cer risk. Prescribed methods are transparent and reproducible and
enable a quantitative synthesis of studies of similar type to esti-
mate quantities of interest and to test hypotheses (Table 5).
However, these methods are considered less feasible, as imple-
mentation is time-consuming and may require specialized compu-
tational and/or statistical skills.
Multicriteria decision analysis requires selected experts to deﬁne
speciﬁc considerations and their relative weighting. Although rele-
vant to a broad range of applications, it is not prescriptive nor repro-
ducible, due to its dependence on the judgment of selected experts.
The outcome is therefore highly sensitive to the judgment of the
participating experts, for whom selection criteria are often not speci-
ﬁed or well described.
The other methods/frameworks considered here, namely,
Bradford Hill, IARC (for some other topics), Epid-Tox, FDA,
GRADE, Hope and Clarkson, OHAT, and SCENIHR, are based
on qualitative or semiquantitative approaches to establishing
LOEs. Most of these methods/frameworks assign a level of evi-
dence or conﬁdence, utility or consistency, according to predeﬁned
scales. Bradford Hill considerations (or modiﬁcations thereof)
continue to be applied when assessing causality of associations in
epidemiological studies (e.g., IARC, Epid-Tox). These approaches
Table 5. Ranking of the methods for establishing lines of evidence.
Approach
Identifying and selecting studiesa
Assessing the quality
of the studiesa
Analyzing a set of studies
of similar typea
PN REL FEA PN REL FEA PN REL FEA
AMSTAR NA NA NA 4 3 4 NA NA NA
Bradford Hill NA NA NA NA NA NA 2 4 4
Epid-Tox NA NA NA 2 4 4 2 4 3
FDA NA NA NA 3 4 4 2 3 3
GRADE NA NA NA 4 3 3 2 3 4
Hope and Clarkson NA NA NA 2 3 3 2 3 3
IARC NA NA NA 2 4 4 2 3 4
ILSI NA NA NA 2 3 3 3 2 3
INCa 3 2 4 3 2 4 NA NA NA
Klimisch NA NA NA 2 3 4 NA NA NA
Meta-analysis NA NA NA NA NA NA 4 4 1
Modified Bradford Hill NA NA NA NA NA NA 3 3 3
Multi-criteria analysis NA NA NA 2 4 3 2 4 3
Navigation Guide 1 3 2 1 3 4 1 3 3
OHAT 3 3 2 3 3 4 2 3 3
SR-Cochrane 3 3 2 2 4 4 NA NA NA
SR-EFSA 3 3 2 NA NA NA NA NA NA
SCENIHR NA NA NA 2 3 4 1 3 4
WCRF/AICR NA NA NA 2 4 4 4 4 2
Weighted Bradford Hill NA NA NA NA NA NA 3 3 3
Note: AMSTAR, Assessing the Methodological Quality of Systematic Reviews; EFSA, European Food Safety Authority; FDA, U.S. Food and Drug Administration; FEA, Feasibility;
GRADE, Grading of Recommendations Assessment, Development and Evaluation; IARC, International Agency for Research on Cancer; ILSI, International Life Sciences Institute;
INCa, Institut National du Cancer/French National Cancer Institute; NA, Not applicable because the corresponding step was not addressed by the approach; NRC, U.S. National
Research Council; OHAT, Office of Health Assessment and Translation; PF, Practical Framework; PN, Prescriptive nature; REL, Relevance; SCENIHR, Scientific Committee on
Emerging and Newly Identified Health Risks; SR, Systematic Review; WCRF/AICR, World Cancer Research Fund and American Institute for Cancer Research.
aThe rankings were assigned to the methods by the authors collectively and reflect relative consideration of each of the three aspects defined and outlined in the Methods and Table 1:
the extent of prescriptive nature contributing to transparency and reproducibility, relevance to be broadly applied within ANSES, and ease of implementation in terms of time and ma-
terial/human resources (feasibility). Each aspect is ranked from 1 (i.e., the least) to 4 (i.e., the most).
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are thus considered relevant and feasible, except GRADE, which
is restricted principally to randomized controlled trials and meta-
analysis. These approaches are not very prescriptive (or transpar-
ent), with results being highly sensitive to expert input; as such,
they have a low degree of reproducibility (Table 5).
Stage 3. Integrating LOEs. Nineteen methods/frameworks
address the integration of LOEs to establish WOE. One category
of methods used to integrate LOEs relies on statistical techniques.
Bayesian inference (BioBayes Group 2015) is highly relevant
to combining experimental data and expert opinion, but it is
rather complex to implement. Thus, although it is prescriptive
and relevant, this method is less feasible due to the complexity
of accessing expert knowledge through elicitation and statistical
methodology to combine experimental data with expert opinion
(Table 6).
A second category of approaches for integrating LOEs
includes semiquantitative methods, i.e., modiﬁed Bradford Hill
(Meek et al. 2014b) and Hope and Clarkson (2014), and qualita-
tive approaches, i.e., IARC (2006), WCRF/AICR (2014), OHAT
(2015), hypothesis-based (Rhomberg 2015), Epid-Tox (Adami
et al. 2011), and INCa (2015), and SCENIHR (2012). These
methods are relevant and feasible, with their extent of prescrip-
tion varying depending on the nature of the expert-informed ex-
perience upon which they draw (i.e., for those where there is
greater experience, the considerations to be taken into account in
integration are often more precisely delineated, drawing on a
larger number of documented examples). For example, assessing
causality in epidemiological studies based on Bradford Hill con-
siderations is commonly quite subjective, which limits the repro-
ducibility of the evaluation (i.e., the results vary considerably,
depending on the experts involved). In the modiﬁed Bradford
Hill approach, as a basis for increasing the consistency and repro-
ducibility of mode of action analyses, selected considerations
have been modiﬁed for the speciﬁc application and precisely
deﬁned and rank ordered (i.e., weighted) by their relative impor-
tance, taking into account acquired experience. Examples of the
types of datasets (integrating epidemiological, toxicological and
mechanistic data) associated with higher or lower conﬁdence are
also provided.
Of the qualitative methods, OHAT is the most prescriptive,
drawing upon a number of previously documented approaches in
clinical medicine. The quality of individual studies (Step 2 of
Stage 2) is evaluated based on responses to up to 15 questions
(depending on study type) to assess the risk of bias. In Stage 3,
preliminary conﬁdence scores developed on this basis are either
downgraded through the assessment of 5 properties of the body
of evidence (risk of bias, unexplained inconsistency, indirectness,
imprecision, and publication bias) or upgraded based on the con-
sideration of another 4 properties (large magnitude of eﬀect, dose
response, residual confounding, and cross-species/population/
study consistency). A comparison of OHAT and IARC, through a
feasibility study of their application in an ANSES assessment of
airborne particulates, indicated that the more prescriptive nature of
OHAT led to greater ease of application, consistency, and reprodu-
cibility (Table 6).
A third category includes the decision tree method and multi-
criteria decision analysis. Multicriteria decision analysis is relevant
when combining any type of data (qualitative or quantitative).
However, considerable expert knowledge is required for its imple-
mentation to identify criteria and their associated weights (i.e.,
limited feasibility), and the results are highly expert-dependent.
For the decision tree method, classiﬁcation rules are expert-
derived and based on acquired experience, taking into considera-
tion diverse types of information, such as experimental studies,
observations, and model outputs. Although feasible and relevant,
decision trees are less prescriptive because there are no associated
evaluation rules (Table 6).
Stage 4. Expressing WOE conclusions. The 13 methods/
frameworks reviewed here address the expression of WOE con-
clusions. Most methods/frameworks use four classes, with an
additional class to indicate that the available data preclude evalu-
ation. Examples of classiﬁcation in methods/frameworks are pre-
sented in Table 7.
Conclusions are illustrated or presented in diﬀerent formats.
OHAT presents the intermediate results in the form of graphs.
NRC conducts an uncertainty analysis on WOE. SCENIHR
expresses uncertainty in the WOE analysis in ﬁve classes (i.e.,
certain, probable, conﬁdent, possible, and uncertain). For multi-
criteria decision analysis, Hristozov et al. (2014a, 2014b) con-
ducted a quantitative uncertainty analysis on data and expert
judgments, whereas Linkov et al. (2011) conducted a sensitivity
analysis on weightings and some input data. Although not neces-
sarily increasing consistency, due to their being mostly dependent
on varying expert input with the often-limited prescription of de-
cision rules, these methods promote transparency in communicat-
ing the basis for the conclusion.
With regard to communication of the outcome, SR-EFSA and
SR-Cochrane specify the topics to be addressed in the discussion
and conclusions. SR-Cochrane relies on EPICOT (i.e., the PICO
structure completed outlining the current state of the evidence and
the date of recommendation) to identify the need and priorities for
research, whereas GRADE structures the conclusions according to
PICO, both of which are addressed initially in problem formula-
tion. Both PICO and EPICOT oﬀer cohesive consideration of
communication at the outset and throughout the assessment.
All the examples of classiﬁcations reviewed here (Table 7)
are considered relevant and feasible for expressing conclusions
of WOE analysis, with varying degrees of prescription (Table 8).
Based on the ratings presented in Tables 4, 5, 6, and 8, several
of the methods performed well for the three criteria considered,
i.e., OHAT, modiﬁed Bradford Hill, AMSTAR, and WCRF/
AICR. Systematic reviews (i.e., SR-Cochrane, SR-EFSA) and
meta-analysis methods are considered prescriptive and relevant
but less feasible.
Table 6. Ranking of the methods for integrating lines of evidence.
Approach Prescriptive naturea Relevancea Feasibilitya
Bayesian inference 3 4 2
Bradford Hill 2 4 4
Decision tree 1 3 3
Epid-Tox 2 4 3
Hope and Clarkson 3 3 3
Hypothesis based 2 3 3
IARC 3 3 4
INCa 3 3 4
Multi-criteria analysis 2 4 3
Modified Bradford Hill 3 3 3
Navigation Guide 1 3 3
OHAT 3 3 4
SCENIHR 2 3 4
WCRF/AICR 3 3 4
Weighted Bradford Hill 3 4 4
Note: IARC, International Agency for Research on Cancer; INCa, Institut National du
Cancer/French National Cancer Institute; OHAT, Office of Health Assessment and
Translation; SCENIHR, Scientific Committee on Emerging and Newly Identified
Health Risks; WCRF/AICR, World Cancer Research Fund and American Institute for
Cancer Research.
aThe rankings were assigned to the methods by the authors collectively and reflect rela-
tive consideration of each of the three aspects defined and outlined in the Methods and
Table 1: the extent of prescriptive nature contributing to transparency and reproducibil-
ity, relevance to be broadly applied within ANSES, and ease of implementation in terms
of time and material/human resources (feasibility). Each aspect is ranked from 1 (i.e.,
the least) to 4 (i.e., the most).
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Discussion
The results of the review described here have illustrated that a
wide range of methods is applied when assessing WOE in hazard
identiﬁcation, most notably and broadly in the environmental
ﬁeld (i.e., to assess eﬀects on human and ecological health in the
general environment).
Developing and documenting the three assessment planning
steps (i.e., scoping, question formulation and protocol for assess-
ment) has contributed to the eﬃcient and cohesive consideration
of priority areas and their transparent communication in assessing
WOE. Assessment protocols are designed considering appropri-
ate and available associated resourcing, taking into account ur-
gency, potential public, and environmental health impacts,
available data, societal issues, and the level of acceptable uncer-
tainty. Consideration of the relative resourcing of various stages
in WOE assessment (i.e., how complex the approach is at each
stage) should also be addressed, commensurate with their likely
impact on the outcome (e.g., the more direct impact of a system-
atic assessment of integration based on prescriptive approaches
at stage 3 versus a systematic review of the literature at stage 1).
Depending on the issues addressed, the existing reporting tem-
plates (PICO, PECO, etc.) reviewed here have contributed to but
have not fully delineated the nature of the required documenta-
tion. In addition, although conceptual models normally address
risk resulting from identiﬁed pathways of exposure, similar ﬁgu-
rative representation of the envisaged steps in assessing WOE in
hazard identiﬁcation may facilitate assessment planning, as part
of formal planning in the iterative deﬁnition of areas of focus and
critical questions and subquestions (U.S. EPA 1998, 2014). The
development of reporting templates for delineating protocols in
assessment planning would facilitate greater transparency, and
potentially consistency, on the basis of the selection of speciﬁc
approaches to weight of evidence assessment, depending on
available resources.
Aspects to be documented in assessment protocols include the
type of literature review (namely, a formally systematic review),
or an in-depth review taking into account the considerations pro-
posed, for example, by EFSA (2010). Protocols for assessing the
quantity and quality of available evidence, including sources and
potential conﬁdentiality, and for integrating conﬂicting results
should be speciﬁed, as well as resources needed to carry out the
review. The assessment protocol should also specify criteria for
the inclusion and exclusion of relevant data based on considera-
tion of the quality and weighting, for integrating studies of a sim-
ilar type. The protocol for establishing and integrating LOEs
Table 7. Example of weight of evidence classifications.
Method/framework Reference
Number of
Classes Class title
Bayesian Inference Schleier et al. (2015) NA NA
Epid-Tox Adami et al. (2011) 4 Likely, Uncertain, Uncertain but plausible, Unlikely (Used to qualify the causal relationship
between the environmental factor and the disease condition)
GRADE Andrews et al. (2013b) 4 Strong Against, Weak Against, Weak For, Strong For
Hope and Clarkson Hope and Clarkson (2014) 5 Weak, Not indicated, Not indicated, Not indicated, Strong
IARC IARC (2006) 5 Group 1: The agent is carcinogenic to humans
Group 2A: The agent is probably carcinogenic to humans
Group 2B: The agent is possibly carcinogenic to humans
Group 3: The agent is not classifiable as to its carcinogenicity to humans
Group 4: The agent is probably not carcinogenic to humans
Modified Bradford Hill Meek et al. (2014a);
OECD (2014)
3 Weak, Moderate, Strong
Multi-criteria analysis Linkov et al. (2011) 6 Do nothing, Institutional control, Clay capping, Mechanical dredging, Hydraulic dredging,
Hot spot dredging
NRC NRC (2014) 5 Carcinogenic to humans, Likely to be carcinogenic to humans, Suggestive evidence of carci-
nogenic potential, Inadequate information to assess carcinogenic potential, Not likely to be
carcinogenic to humans
OHAT OHAT (2015) 5 (1) Known to be a hazard to humans, (2) Presumed to be a hazard to humans, (3) Suspected
to be a hazard to humans, (4) Not classifiable as a hazard to humans, or (5) Not identified
as a hazard to humans
SR–Cochrane Higgins and Green (2011) 4 Very low, Low, Moderate, Strong
SR-EFSA EFSA (2010) NA NA
SCENIHR SCENIHR (2012) 5 Weighting not possible, Uncertain, Weak, Moderate, Strong
WCRF/AICR WCRF/AICR (2014) 5 Convincing/Probable/Limited - suggestive/Limited - no conclusion/Substantial effect on risk
unlikely
Note: EFSA, European Food Safety Authority; GRADE, Grading of Recommendations Assessment, Development and Evaluation; NA, Not applicable because the corresponding step
was not addressed by the approach; NRC, U.S. National Research Council; OHAT, Office of Health Assessment and Translation; SCENIHR, Scientific Committee on Emerging and
Newly Identified Health Risks; SR, Systematic Review; WCRF/AICR, World Cancer Research Fund and American Institute for Cancer Research.
Table 8. Ranking of the methods for expressing weight of evidence
conclusions.
Approach Prescriptive naturea Relevancea Feasibilitya
Bayesian inference 3 4 2
Epid-Tox 3 4 4
GRADE 3 4 4
Hope and Clarkson 3 3 3
IARC 3 4 4
Modified Bradford Hill 3 2 3
Multi-criteria analysis 3 3 3
NRC 3 4 3
OHAT 3 4 4
SR-Cochrane 4 4 3
SR-EFSA 4 4 3
SCENIHR 3 4 3
WCRF/AICR 4 3 4
Note: EFSA, European Food Safety Authority; GRADE, Grading of Recommendations
Assessment, Development and Evaluation; IARC, International Agency for Research on
Cancer; NRC, U.S. National Research Council; OHAT, Office of Health Assessment
and Translation; SCENIHR, Scientific Committee on Emerging and Newly Identified
Health Risks; SR, Systematic Review.
aThe rankings were assigned to the methods by the authors collectively and reflect rela-
tive consideration of each of the three aspects defined and outlined in the Methods and
Table 1: the extent of prescriptive nature contributing to transparency and reproducibil-
ity, relevance to be broadly applied within ANSES, and ease of implementation in terms
of time and material/human resources (feasibility). Each aspect is ranked from 1 (i.e.,
the least) to 4 (i.e., the most).
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should also be speciﬁed, along with estimated resources for con-
ducting the assessment. Developing and completing prerequisite
reporting templates for the assessment protocol would improve
transparency for the rationale for selecting methods in WOE
assessment, such as partial or full/directed systematic reviews,
meta-analyses, and Bayesian inference.
We analyzed the frameworks and methods (namely, to iden-
tify the extent of the prescriptive nature, relevance, and feasibil-
ity) and found that preferred methods are often the least feasible
(i.e., the most complex requiring, for example, specialized exper-
tise), due to limited resources (e.g., lack of expertise or time).
This ﬁnding underscores the need for transparent, easily adapta-
ble, and broadly applicable communicative methods that draw on
collective expertise. Due to limited resources, it is expected that
the application of the more complex approaches for which feasi-
bility has been judged as low in the current study (e.g., Bayesian
analysis and meta-analysis) will understandably be limited,
based on careful consideration of the abovementioned factors,
including the importance of the question at hand, urgency, and
available resources. However, implementation of these complex
approaches can lead to greater eﬃciency in public health protec-
tion through a more systematic allocation of resources than is
currently made. The availability of a documented assessment
protocol addressing delineated considerations in reporting tem-
plates should also enhance common understanding of (some-
times limited) objectives and facilitate the provision of early
input to modify the selection of appropriate methods and alloca-
tion of associated resources.
The results of this review have also indicated that the princi-
ples of the limited range of methods identiﬁed as being relevant
to potentially the most inﬂuential stages of WOE assessment—
namely, the later steps of stage 2 (integration within an LOE) and
3 (integration of LOEs)—are similar and relate essentially to
expert-informed weighting of components. These methods range
from qualitative to semiquantitative to fully quantitative. Expert-
informed experience is derived from a formal analysis of previ-
ous examples in deﬁning relevant considerations and their rela-
tive weighting. This analysis is distinct from expert judgment of
an individual or group, for which relevant criteria and weightings
are often not well speciﬁed.
Bradford Hill considerations have ﬁgured prominently in this
integration but have varied depending on the extent of their pre-
scriptive nature and the ﬁeld of application (e.g., epidemiological
studies, mode of action or integration of epidemiological and tox-
icological data, based on the consideration of mode of action).
The extent to which these methods have been prescribed, taking
into account previous expert-informed experience, contributes
most to their consistency and reproducibility.
The approaches identiﬁed have been based on qualitative,
semiquantitative, or quantitative techniques to establish LOEs
and WOE, consistent with the WOE classiﬁcation system pro-
posed by Linkov et al. (2009). Although quantitative methods are
more rigorous (i.e., prescriptive), their implementation (stages 2
and 3) requires speciﬁc knowledge of elicitation and statistical
methodology. In contrast, purely qualitative methods for estab-
lishing LOEs, such as Bradford Hill considerations in assessing
causality in epidemiological studies, require fewer resources to
implement. However, their transparency is limited, often leading
to diﬀerent conclusions by diﬀerent groups, the basis for which is
unclear. Semiquantitative, more prescriptive methods, such as
OHAT and modiﬁed Bradford Hill, oﬀer, then, a valuable inter-
mediate option that conserves resources but also increases the
transparency and consistency of assessments.
The delineation of conclusions in various deﬁned classiﬁca-
tions also contributes to transparency. The nature of these
descriptions requires careful consideration, to avoid, as far as
possible, the misinterpretation that higher classiﬁcations infer
greater hazard; rather, they indicate greater preponderance of
evidence. Brief, plain-language descriptions of the nature and
extent of evidence and graphical illustrations may be preferred
over less clear descriptors such as “probably,” “possibly,” and
“potentially.”
The results of this review have also indicated that methods
have been broadly applied in some application ﬁelds, such as envi-
ronmental health or human food and nutrition (cf. Table 3).
However, the seeming lack of application in some ﬁelds for certain
methods may be a function of speciﬁc assessment needs or, for
example, the restricted date range of the literature review. For
example, the sole method identiﬁed here as enabling an assessment
of the quality of study syntheses is R-AMSTAR; all the other iden-
tiﬁed methods are based exclusively on the quality of individual
studies to establish LOEs. Although R-AMSTAR has mostly been
adopted in the medical sector, it could be applied in a range of dis-
ciplines, given the broad relevance of its rather generic contents. In
other applications and disciplines (e.g., Plant Health), WOE analy-
sis is not referenced. This ﬁnding relates in part to variations in ter-
minology and requirements in diﬀerent application ﬁelds (e.g.,
although not explicitly mentioned, the decision-support scheme for
pest risk analysis developed by the European and Mediterranean
Plant Protection Organization addresses WOE).
Consequently, the current work contributes to relate primarily
to considering the principles of existing methods and assessing
their potential utility in a broad range of application areas rele-
vant to the purview of ANSES. We considered a number of char-
acteristics of each method as a basis for method selection in
assessment planning, including the extent of prescription, rele-
vance, and ease of implementation (feasibility). We additionally
used a series of case studies for selected ongoing or completed
assessments in a range of diﬀerent applications at ANSES
(ANSES 2017) to further evaluate the value of these characteris-
tics to screening for planning and conducting assessments. Two
limitations of the current study were the fact that we restricted
our consideration of WOE analysis to hazard identiﬁcation alone
and the fact that the interrelationships between WOE and uncer-
tainty analysis were not explicitly considered. We plan to develop
and integrate these aspects in future research, in further consider-
ation of the working group’s recommendations by ANSES.
In addition, it is important to note that the scores developed
for the prescriptive nature, relevance, and feasibility of various
methods are meaningful in a relative context only and are limited
to generalized considerations for assessment. They mostly reﬂect
the extent and documentation of expert judgment and ease of
application across a broad range of applications. Applying each
of the methods to speciﬁc assessments is necessarily dependent
on case-speciﬁc objectives and conditions, as indicated in prob-
lem formulation.
The results of the current analysis indicate that ultimately,
over the short term, transparency is critical in increasing conﬁ-
dence and, over the long term, is critical to potentially increas-
ing consistency in WOE analysis, within deﬁned constraints of
assessment planning. Identiﬁed outstanding areas that are rele-
vant for considering the quality of studies when establishing
LOEs and their weighted integration include delineating criteria
for the consideration of additional factors, such as selection cri-
teria for experts.
Conclusions
The documentation of planning, taking into account factors out-
lined for each of the approaches reviewed here (namely, extent of
prescription, relevance to the question at hand and ease of
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implementation), considerably increases transparency in the ra-
tionale for the justiﬁed adoption of diﬀerent approaches based on
factors such as urgency and the extent of available resources. This
ﬁnding should increase common understanding of the constraints
that provide a legitimate basis for variations in the approaches
taken when considering WOE. Development and application of
reporting templates for assessment planning outlining speciﬁc
aspects to be addressed will likely increase common understanding
of the appropriate nature of required transparency in the selection
of assessment methods.
The current review also highlighted the value of acquired ex-
perience in contributing to expert-informed prescription of the
relevant factors to be considered in reporting templates, as a basis
for increasing the transparency and defensibility of WOE analy-
sis. This aspect is particularly important for establishing and inte-
grating LOEs. All WOE assessments include elements of expert-
informed judgments. However, transparency regarding the nature
and basis of those judgments in individual assessments (often
attributed to “expert judgment”) is often lacking. Developing pre-
scriptive reporting templates based on collective expert experi-
ence increases common understanding of important elements for
consideration and their relative weighting. This, in turn, contrib-
utes to more consistent evaluations, but necessarily requires that
contributing experts be much more explicit about the factors
being taken into consideration. For example, OHAT provides a
relatively prescriptive and transparent approach to assessment
planning, review and evaluation, which facilitates adoption and is
likely to increase common understanding of relevant elements for
consideration. The generic utility of this approach has been illus-
trated in assessments of the National Toxicology Program (U.S.
NTP 2015) and in a range of case studies conducted by various
organizations (e.g., EFSA and ANSES). However, it does not yet
robustly address mechanistic data. Integrating experience from
more mechanistically driven approaches, such as the application
of modiﬁed Bradford Hill considerations as a basis for consider-
ing patterns of epidemiological, toxicological, and mechanistic
data in mode of action analyses, may well inform its additional
development. IARC classiﬁcations, on the other hand, result from
the consideration of a much less prescriptive approach by a con-
vened group of experts and, as such, reﬂect less documented and
variable expert judgment, as does multicriteria decision analysis.
Explicit criteria for selecting experts and process considerations
concerning the weighting of their input seem essential to ensure
greater transparency in these more judgment-dependent methodol-
ogies. However, reporting templates that draw much more broadly
on previous collective experience, deﬁning speciﬁc aspects taken
into consideration and the nature of their relative weighting, are
preferred.
Prescriptive generic approaches providing an encompassing
framework, such as OHAT, that draw broadly on an analysis of
experience acquired in application and less on consensus expert
opinion, are likely to oﬀer the greatest transparency and consis-
tency in WOE analysis. Speciﬁc issues identiﬁed, when planning
an assessment, require a combination of these more generic
frameworks with specialized approaches (e.g., those used to con-
sider the extent of mechanistic support for competing hypotheses
in mechanistically motivated integration of LOEs). Selecting
expert-informed prescriptive approaches (versus consensus based
on expert judgment) is likely to provide the greatest transparency
and, potentially, the greatest consistency of evaluations within
identiﬁed constraints.
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